Ensitrelvir can shorten symptoms of mild to moderate COVID-19 by about a day Ensitrelvir, a new antiviral drug, has been shown to shorten symptoms of mild to moderate COVID-19 and moreover, it has the potential to prevent long COVID, study has shown.
Here's all you need to know about the drug, can it really prevent long COVID and why the experts are still skeptical about it.
Ensitrelvir has been developed by Shionogi in Osaka, Japan and they claim that it shorten symptoms of mild to moderate COVID-19 by about a day and reduce the number of days people test positive for coronavirus.
The trial data was presented at the Conference on Retroviruses and Opportunistic Infections. The trial involved roughly 1,200 people and aimed to determine whether the drug could accelerate recovery.